Yingsi Zhou
Shanghai, 200131, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Author Correction: Engineering TadA ortholog-derived cytosine base editor without motif preference and adenosine activity limitation.
Journal: Nature communications
Published: October 18, 2024
Engineering TadA ortholog-derived cytosine base editor without motif preference and adenosine activity limitation.
Journal: Nature communications
Published: February 08, 2024
Repurposing Type I-A CRISPR-Cas3 for a robust diagnosis of human papillomavirus (HPV).
Journal: Communications biology
Published: October 12, 2023
Enhanced C-To-T and A-To-G Base Editing in Mitochondrial DNA with Engineered DdCBE and TALED.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 21, 2023
Engineering a transposon-associated TnpB-ωRNA system for efficient gene editing and phenotypic correction of a tyrosinaemia mouse model.
Journal: Nature communications
Published: May 26, 2023
Programmable deaminase-free base editors for G-to-Y conversion by engineered glycosylase.
Journal: National science review
Published: April 24, 2023
Engineered CRISPR-OsCas12f1 and RhCas12f1 with robust activities and expanded target range for genome editing.
Journal: Nature communications
Published: January 06, 2023
Develop a Compact RNA Base Editor by Fusing ADAR with Engineered EcCas6e.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 20, 2022
In vivo treatment of tyrosinaemia with hypercompact Cas12f1.
Journal: Cell discovery
Published: November 16, 2022
Last Updated: 09/26/2026